REVOLUTION Medicines
Eric Chown currently serves as SVP of Global Commercial Development at Revolution Medicines, a position held since September 2025. Prior experience includes serving as US Commercial Lead at Summit Therapeutics, Owner of Chown Global Biopharma Consulting LLC, and various roles at Seagen, where responsibilities included Vice President and Executive Director of Commercial Development and Global Marketing from January 2017 to April 2024. Eric also worked at Astellas Pharma US from 2012 to 2017, focusing on oncology marketing initiatives, and held multiple commercial roles at Amgen and Genentech from 2004 to 2012. Educational qualifications include a Global MBA in International Business from Thunderbird School of Global Management and a Bachelor's degree in Economics and Political Science from UC San Diego.
This person is not in any teams
This person is not in any offices